Jefferies Financial Group Inc. Sarepta Therapeutics, Inc. Transaction History

Jefferies Financial Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$93.7 - $141.53 $5.43 Million - $8.2 Million	-57,933 Reduced 88.13%	7,800 $1.01 Million
Q4 2023 Feb 13, 2024	BUY	$67.31 - $124.76 $4.42 Million - $8.2 Million	65,733 New	65,733 $6.34 Million
Q2 2023 Aug 14, 2023	SELL	$106.4 - $157.19 $368,463 - $544,348	-3,463 Reduced 49.78%	3,494 $400,000
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $7.77 Million - $10.3 Million	-66,143 Reduced 90.48%	6,957 $958,000
Q4 2022 Sep 21, 2023	BUY	$100.86 - $132.13 $6.64 Million - $8.69 Million	65,798 Added 1883.17%	69,292 $8.98 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $7.37 Million - $9.66 Million	73,100 New	73,100 $9.47 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.